DSG3 (Desmoglein 3) Gene: Structure, Function, and Clinical Significance

Comprehensive biomedical overview of the DSG3 gene, encoding desmoglein 3, a cadherin family member critical for desmosome adhesion in epithelial tissues.

Gene Information Card

Symbol DSG3
Full Name Desmoglein 3
Gene Type Protein coding
Chromosomal Location 18q12.1
NCBI Gene ID 1830 ncbi.nlm.nih.gov/gene/1830
Ensembl ID ENSG00000134757
UniProt ID P32926
OMIM ID 169615
HGNC ID 3049
Aliases CDHF6, DG3, DSG, PVA

Description

DSG3 (desmoglein 3) is a protein-coding gene located on chromosome 18q12.1. It encodes a calcium-binding transmembrane glycoprotein belonging to the desmoglein subfamily of cadherins. Desmoglein 3 is a core component of desmosomes, intercellular junctions that provide mechanical strength to epithelial tissues. The protein is primarily expressed in stratified squamous epithelia, including skin and oral mucosa. DSG3 is a target of autoantibodies in pemphigus vulgaris, an autoimmune blistering disease. Mutations and altered expression of DSG3 have also been implicated in cancer progression and metastasis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Pemphigus vulgaris Autoantibodies against DSG3 disrupt desmosome adhesion, leading to acantholysis and blister formation in skin and mucous membranes. ClinVar, OMIM
Pemphigus foliaceus Autoantibodies primarily target DSG1, but DSG3 may be involved in some cases. OMIM
Oral squamous cell carcinoma DSG3 overexpression is associated with tumor invasion and poor prognosis. COSMIC, NCBI Gene
Breast cancer DSG3 downregulation correlates with epithelial-mesenchymal transition and metastasis. NCBI Gene, COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 58.2 High
Oral mucosa 45.1 High
Esophagus 32.7 Medium
Tongue 28.4 Medium
Cervix 15.3 Low
Cell Line Expression
Cell Line nTPM Notes
HaCaT (keratinocyte) 62.5 High expression
A431 (epidermoid carcinoma) 55.0 High expression
SCC-25 (oral squamous cell carcinoma) 48.3 High expression
MCF-7 (breast cancer) 2.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1250G>A (p.Arg417His) Missense Rare Alters cadherin domain, possibly affecting adhesion
c.2023C>T (p.Arg675Cys) Missense Rare Located in extracellular domain, potential impact on autoantibody binding
c.2860_2861del (p.Leu954fs) Frameshift Very rare Truncated protein, loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., p.Leu954fs) lead to truncated protein and loss of adhesive function.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in DSG3.

Dominant Negative (DN)

Missense mutations in the extracellular domain may interfere with desmosome assembly, acting in a dominant-negative manner.

Gene Ontology (GO)

• calcium ion binding • cell adhesion
• desmosome organization • homophilic cell adhesion via plasma membrane adhesion molecules
• keratinocyte differentiation • cell-cell junction assembly

Pathways

• Cell adhesion molecules (CAMs)
• Desmosome assembly
• Keratinocyte differentiation
• Pemphigus vulgaris signaling

Protein Summary

Desmoglein 3 is a 999-amino-acid transmembrane glycoprotein with an extracellular domain containing four cadherin repeats and a calcium-binding site, a single transmembrane domain, and a cytoplasmic tail that interacts with plakoglobin and desmoplakin to anchor intermediate filaments. It is essential for maintaining structural integrity in stratified epithelia. Autoantibodies targeting DSG3 cause pemphigus vulgaris, while altered expression is linked to cancer invasion and metastasis.

Related Products

Product name Cat.No. Species Gene ID
DSG3 Knockout HEK293 Cell Line EDJ-KQ3365 Human 1830 Details Get a Quote
DSG3 Knockout HeLa Cell Line EDJ-KQ53123 Human 1830 Details Get a Quote
DSG3 Knockout A-549 Cell Line EDJ-KQ61595 Human 1830 Details Get a Quote
DSG3 Knockout HCT 116 Cell Line EDJ-KQ70085 Human 1830 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: